Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.
Latest website image capture
Clouds background image

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s revision history. The change does not modify content or user-facing features.
    Difference
    0.0%
    Check dated 2026-05-15T04:57:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Updated the study location entry to Malmö, Sweden, SE-205 02. The previous listing Malmo, Sweden, SE-205 02 was replaced to reflect the correct spelling.
    Difference
    0.0%
    Check dated 2026-05-08T00:43:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a refreshed version of the content with minor edits to the study record.
    Difference
    0.0%
    Check dated 2026-04-30T17:23:37.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revisions were updated to replace v3.5.0 with v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:09:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision 3.5.0 was added to the revision history, and Revision 3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:09:03.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:53:50.000Z thumbnail image

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.